Showing results (221-230 of 293) with videos related to

Sort By:
Pageof 30
Eclinicalmedicine|September 1, 2023
The effects of COVID-19 on cognitive performance in a community-based cohort: a COVID symptom study biobank prospective cohort studyNathan J Cheetham, Rose Penfold, Valentina Giunchiglia, et al.
Wellcome Open Research|October 9, 2023
The Challenge Non-Typhoidal Salmonella (CHANTS) Consortium: Development of a non-typhoidal Salmonella controlled human infection model: Report from a consultation group workshop, 05 July 2022, London, UKChristopher Smith, Emma Smith, Christopher Chiu, et al.
Plos Pathogens|March 29, 2014
Broadly reactive human CD8 T cells that recognize an epitope conserved between VZV, HSV and EBVChristopher Chiu, Megan McCausland, John Sidney, et al.
BMC Bioinformatics|March 8, 2020
CNV Radar: an improved method for somatic copy number alteration characterization in oncologyDavid Soong, Jeran Stratford, Herve Avet-Loiseau, et al.
Oncoimmunology|February 8, 2021
Cyclophosphamide alters the tumor cell secretome to potentiate the anti-myeloma activity of daratumumab through augmentation of macrophage-mediated antibody dependent cellular phagocytosisSerika D Naicker, Claire L Feerick, Kevin Lynch, et al.
Blood|June 23, 2017
Daratumumab plus pomalidomide and dexamethasone in relapsed and/or refractory multiple myelomaAjai Chari, Attaya Suvannasankha, Joseph W Fay, et al.
Clinical Lymphoma, Myeloma & Leukemia|June 3, 2020
Daratumumab, Bortezomib, and Dexamethasone Versus Bortezomib and Dexamethasone in Patients With Previously Treated Multiple Myeloma: Three-year Follow-up of CASTORMaria-Victoria Mateos, Pieter Sonneveld, Vania Hungria, et al.
Blood Advances|January 4, 2018
Effects of daratumumab on natural killer cells and impact on clinical outcomes in relapsed or refractory multiple myelomaTineke Casneuf, Xu Steven Xu, Homer C Adams, et al.
Nature Microbiology|April 2, 2021
Detection of respiratory syncytial virus defective genomes in nasal secretions is associated with distinct clinical outcomesSébastien A Felt, Yan Sun, Agnieszka Jozwik, et al.
Nature Communications|June 11, 2026
Influenza coinfection inhibits control of mycobacterial infection in a human challenge modelClaire M Broderick, Oliver Powell, Sam Nichols, et al.
Pageof 30